Nandrolone Survey: Please Participate

Nelson Vergel

Founder, ExcelMale.com
Forwarding for a friend who is collecting data for his Doctorate.




My name is Todd Kielman. I am a Physician Assistant and Sexual Medicine Specialist with emphasis on Men's Health and Hormone Replacement. In collaboration with Nelson Vergel, we are conducting a study into the use and effects of Nandrolone Decanoate as part of a comprehensive Testosterone Replacement Regimen. If you have ever used Nandrolone as part of your program, and you would be interested in adding to the growing pool of information on this medication, please consider participating. If you meet the below criteria for the study, please go to the website. There is no risk to you. All answers are anonymous and will not be connected to you in any way. Further, there will also be no compensation of any kind, other than increasing the knowledge of this medication to the Sexual Medicine specialists. Further, this study will possibly educate primary care providers, and those treating TRT with limited knowledge of adjunct treatments.



Participant Criteria

1. Biological Male

2. Age 18 or Older

3. Have ever used Testosterone

4. Have ever used Nandrolone Decanoate.



If you meet the criteria for this study and would like to participate, the survey is open right now. Just go to the below address.



Nandrolone Decanoate: Uses and Effects Survey

HAVE YOU USED NANDROLONE.jpg
 

Nelson Vergel

Founder, ExcelMale.com
 

Nelson Vergel

Founder, ExcelMale.com
 

Guided_by_Voices

Active Member
I'd like to participate, but why is this limited to Deca and excludes NPP? I know that NPP is easily available in fewer regions, however given the (anecdotal but widely reported) reduction in side effects from NPP as well as the generally lower risk profile of shorter esters (at least for new users) I would think that one of the most important potential aspects of increasing the low-risk use of Nandrolone would be to generate data to make the case that NPP should be more widely available. Also, if Nandrolone is ever going to be viable for users not on TRT, I would think the intermittent nature of NPP would be less suppressive and a much better option. I think it is unfortunate that so many people treat the Deca version of Nandrolone as synonymous with all Nandrolone, which is an overly US-centric view.
 

Nelson Vergel

Founder, ExcelMale.com
This is a doctorate that will focus on a FDA approved anabolic agent. Most of us have not tried NPP since it cannot be prescribed in the US. And at least we have animal data on nandrolone decanoate and pilot human data on joint pain improvements.
 

madman

Member
I'd like to participate, but why is this limited to Deca and excludes NPP? I know that NPP is easily available in fewer regions, however given the (anecdotal but widely reported) reduction in side effects from NPP as well as the generally lower risk profile of shorter esters (at least for new users) I would think that one of the most important potential aspects of increasing the low-risk use of Nandrolone would be to generate data to make the case that NPP should be more widely available. Also, if Nandrolone is ever going to be viable for users not on TRT, I would think the intermittent nature of NPP would be less suppressive and a much better option. I think it is unfortunate that so many people treat the Deca version of Nandrolone as synonymous with all Nandrolone, which is an overly US-centric view.

NPP has no special properties let alone advantages over ND other than a shorter half-life.

Regardless of the ester used once cleaved nandrolone is nandrolone.

NPP is in no way less suppressive to the hpta than ND.

As far as side-effects dose/duration is key.




William Llewellyn's ANABOLICS

Durabolin®
(nandrolone phenylpropionate)

Description:


Nandrolone phenylpropionate is an injectable form of the anabolic steroid nandrolone. The properties of this drug are strikingly similar to those of Deca-Durabolin®, which uses the slower acting drug nandrolone decanoate. The primary difference between these two preparations is the speed in which nandrolone is released into the blood. While nandrolone decanoate provides a release of nandrolone from the area of injection lasting approximately 3 weeks, nandrolone phenylpropionate is active for only about a week. In clinical situations, Deca-Durabolin can thus be injected once every 2 or 3 weeks, while Durabolin® is usually administered every several days to once weekly. Otherwise, the two drugs are virtually interchangeable. Like DecaDurabolin, Durabolin is valued by athletes and bodybuilders for its abilities to promote strength and lean muscle mass gains without significant estrogenic or androgenic side effects.




Side Effects (Testosterone Suppression):

All anabolic/androgenic steroids when taken in doses sufficient to promote muscle gain are expected to suppress endogenous testosterone production. Studies administering 100 mg injection of nandrolone phenylpropionate demonstrated a rapid suppression of serum testosterone following a single injection. Testosterone levels declined to approximately 30% of initial level by day 3 after drug administration, and stayed suppressed for approximately 13 days. Regular use is expected to significantly lengthen the endogenous hormone recovery window. It is believed that the progestational activity of nandrolone notably contributes to the suppression of testosterone synthesis during therapy, which can be marked in spite of a low tendency for estrogen conversion.480 Without the intervention of testosterone stimulating substances, testosterone levels should return to normal within 2-6 months of drug secession. Note that prolonged hypogonadotrophic hypogonadism can develop secondary to steroid abuse, necessitating medical intervention.
 
Top